Cargando…

Assessment of the Activity of Decoquinate and Its Quinoline-O-Carbamate Derivatives against Toxoplasma gondii In Vitro and in Pregnant Mice Infected with T. gondii Oocysts

The quinolone decoquinate (DCQ) is widely used in veterinary practice for the treatment of bacterial and parasitic infections, most notably, coccidiosis in poultry and in ruminants. We have investigated the effects of treatment of Toxoplasma gondii in infected human foreskin fibroblasts (HFF) with D...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramseier, Jessica, Imhof, Dennis, Anghel, Nicoleta, Hänggeli, Kai, Beteck, Richard M., Balmer, Vreni, Ortega-Mora, Luis-Miguel, Sanchez-Sanchez, Roberto, Ferre, Ignacio, Haynes, Richard K., Hemphill, Andrew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8587999/
https://www.ncbi.nlm.nih.gov/pubmed/34770802
http://dx.doi.org/10.3390/molecules26216393
_version_ 1784598325114175488
author Ramseier, Jessica
Imhof, Dennis
Anghel, Nicoleta
Hänggeli, Kai
Beteck, Richard M.
Balmer, Vreni
Ortega-Mora, Luis-Miguel
Sanchez-Sanchez, Roberto
Ferre, Ignacio
Haynes, Richard K.
Hemphill, Andrew
author_facet Ramseier, Jessica
Imhof, Dennis
Anghel, Nicoleta
Hänggeli, Kai
Beteck, Richard M.
Balmer, Vreni
Ortega-Mora, Luis-Miguel
Sanchez-Sanchez, Roberto
Ferre, Ignacio
Haynes, Richard K.
Hemphill, Andrew
author_sort Ramseier, Jessica
collection PubMed
description The quinolone decoquinate (DCQ) is widely used in veterinary practice for the treatment of bacterial and parasitic infections, most notably, coccidiosis in poultry and in ruminants. We have investigated the effects of treatment of Toxoplasma gondii in infected human foreskin fibroblasts (HFF) with DCQ. This induced distinct alterations in the parasite mitochondrion within 24 h, which persisted even after long-term (500 nM, 52 days) treatment, although there was no parasiticidal effect. Based on the low half-maximal effective concentration (IC(50)) of 1.1 nM and the high selectivity index of >5000, the efficacy of oral treatment of pregnant mice experimentally infected with T. gondii oocysts with DCQ at 10 mg/kg/day for 5 days was assessed. However, the treatment had detrimental effects, induced higher neonatal mortality than T. gondii infection alone, and did not prevent vertical transmission. Thus, three quinoline-O-carbamate derivatives of DCQ, anticipated to have better physicochemical properties than DCQ, were assessed in vitro. One such compound, RMB060, displayed an exceedingly low IC(50) of 0.07 nM, when applied concomitantly with the infection of host cells and had no impact on HFF viability at 10 µM. As was the case for DCQ, RMB060 treatment resulted in the alteration of the mitochondrial matrix and loss of cristae, but the changes became apparent at just 6 h after the commencement of treatment. After 48 h, RMB060 induced the expression of the bradyzoite antigen BAG1, but TEM did not reveal any other features reminiscent of bradyzoites. The exposure of infected cultures to 300 nM RMB060 for 52 days did not result in the complete killing of all tachyzoites, although mitochondria remained ultrastructurally damaged and there was a slower proliferation rate. The treatment of mice infected with T. gondii oocysts with RMB060 did reduce parasite burden in non-pregnant mice and dams, but vertical transmission to pups could not be prevented.
format Online
Article
Text
id pubmed-8587999
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-85879992021-11-13 Assessment of the Activity of Decoquinate and Its Quinoline-O-Carbamate Derivatives against Toxoplasma gondii In Vitro and in Pregnant Mice Infected with T. gondii Oocysts Ramseier, Jessica Imhof, Dennis Anghel, Nicoleta Hänggeli, Kai Beteck, Richard M. Balmer, Vreni Ortega-Mora, Luis-Miguel Sanchez-Sanchez, Roberto Ferre, Ignacio Haynes, Richard K. Hemphill, Andrew Molecules Article The quinolone decoquinate (DCQ) is widely used in veterinary practice for the treatment of bacterial and parasitic infections, most notably, coccidiosis in poultry and in ruminants. We have investigated the effects of treatment of Toxoplasma gondii in infected human foreskin fibroblasts (HFF) with DCQ. This induced distinct alterations in the parasite mitochondrion within 24 h, which persisted even after long-term (500 nM, 52 days) treatment, although there was no parasiticidal effect. Based on the low half-maximal effective concentration (IC(50)) of 1.1 nM and the high selectivity index of >5000, the efficacy of oral treatment of pregnant mice experimentally infected with T. gondii oocysts with DCQ at 10 mg/kg/day for 5 days was assessed. However, the treatment had detrimental effects, induced higher neonatal mortality than T. gondii infection alone, and did not prevent vertical transmission. Thus, three quinoline-O-carbamate derivatives of DCQ, anticipated to have better physicochemical properties than DCQ, were assessed in vitro. One such compound, RMB060, displayed an exceedingly low IC(50) of 0.07 nM, when applied concomitantly with the infection of host cells and had no impact on HFF viability at 10 µM. As was the case for DCQ, RMB060 treatment resulted in the alteration of the mitochondrial matrix and loss of cristae, but the changes became apparent at just 6 h after the commencement of treatment. After 48 h, RMB060 induced the expression of the bradyzoite antigen BAG1, but TEM did not reveal any other features reminiscent of bradyzoites. The exposure of infected cultures to 300 nM RMB060 for 52 days did not result in the complete killing of all tachyzoites, although mitochondria remained ultrastructurally damaged and there was a slower proliferation rate. The treatment of mice infected with T. gondii oocysts with RMB060 did reduce parasite burden in non-pregnant mice and dams, but vertical transmission to pups could not be prevented. MDPI 2021-10-22 /pmc/articles/PMC8587999/ /pubmed/34770802 http://dx.doi.org/10.3390/molecules26216393 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Ramseier, Jessica
Imhof, Dennis
Anghel, Nicoleta
Hänggeli, Kai
Beteck, Richard M.
Balmer, Vreni
Ortega-Mora, Luis-Miguel
Sanchez-Sanchez, Roberto
Ferre, Ignacio
Haynes, Richard K.
Hemphill, Andrew
Assessment of the Activity of Decoquinate and Its Quinoline-O-Carbamate Derivatives against Toxoplasma gondii In Vitro and in Pregnant Mice Infected with T. gondii Oocysts
title Assessment of the Activity of Decoquinate and Its Quinoline-O-Carbamate Derivatives against Toxoplasma gondii In Vitro and in Pregnant Mice Infected with T. gondii Oocysts
title_full Assessment of the Activity of Decoquinate and Its Quinoline-O-Carbamate Derivatives against Toxoplasma gondii In Vitro and in Pregnant Mice Infected with T. gondii Oocysts
title_fullStr Assessment of the Activity of Decoquinate and Its Quinoline-O-Carbamate Derivatives against Toxoplasma gondii In Vitro and in Pregnant Mice Infected with T. gondii Oocysts
title_full_unstemmed Assessment of the Activity of Decoquinate and Its Quinoline-O-Carbamate Derivatives against Toxoplasma gondii In Vitro and in Pregnant Mice Infected with T. gondii Oocysts
title_short Assessment of the Activity of Decoquinate and Its Quinoline-O-Carbamate Derivatives against Toxoplasma gondii In Vitro and in Pregnant Mice Infected with T. gondii Oocysts
title_sort assessment of the activity of decoquinate and its quinoline-o-carbamate derivatives against toxoplasma gondii in vitro and in pregnant mice infected with t. gondii oocysts
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8587999/
https://www.ncbi.nlm.nih.gov/pubmed/34770802
http://dx.doi.org/10.3390/molecules26216393
work_keys_str_mv AT ramseierjessica assessmentoftheactivityofdecoquinateanditsquinolineocarbamatederivativesagainsttoxoplasmagondiiinvitroandinpregnantmiceinfectedwithtgondiioocysts
AT imhofdennis assessmentoftheactivityofdecoquinateanditsquinolineocarbamatederivativesagainsttoxoplasmagondiiinvitroandinpregnantmiceinfectedwithtgondiioocysts
AT anghelnicoleta assessmentoftheactivityofdecoquinateanditsquinolineocarbamatederivativesagainsttoxoplasmagondiiinvitroandinpregnantmiceinfectedwithtgondiioocysts
AT hanggelikai assessmentoftheactivityofdecoquinateanditsquinolineocarbamatederivativesagainsttoxoplasmagondiiinvitroandinpregnantmiceinfectedwithtgondiioocysts
AT beteckrichardm assessmentoftheactivityofdecoquinateanditsquinolineocarbamatederivativesagainsttoxoplasmagondiiinvitroandinpregnantmiceinfectedwithtgondiioocysts
AT balmervreni assessmentoftheactivityofdecoquinateanditsquinolineocarbamatederivativesagainsttoxoplasmagondiiinvitroandinpregnantmiceinfectedwithtgondiioocysts
AT ortegamoraluismiguel assessmentoftheactivityofdecoquinateanditsquinolineocarbamatederivativesagainsttoxoplasmagondiiinvitroandinpregnantmiceinfectedwithtgondiioocysts
AT sanchezsanchezroberto assessmentoftheactivityofdecoquinateanditsquinolineocarbamatederivativesagainsttoxoplasmagondiiinvitroandinpregnantmiceinfectedwithtgondiioocysts
AT ferreignacio assessmentoftheactivityofdecoquinateanditsquinolineocarbamatederivativesagainsttoxoplasmagondiiinvitroandinpregnantmiceinfectedwithtgondiioocysts
AT haynesrichardk assessmentoftheactivityofdecoquinateanditsquinolineocarbamatederivativesagainsttoxoplasmagondiiinvitroandinpregnantmiceinfectedwithtgondiioocysts
AT hemphillandrew assessmentoftheactivityofdecoquinateanditsquinolineocarbamatederivativesagainsttoxoplasmagondiiinvitroandinpregnantmiceinfectedwithtgondiioocysts